Intron-derived aberrant splicing of A20 transcript in rheumatoid arthritis
Open Access
- 12 November 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 52 (3) , 427-437
Abstract
Objective. Aberrant splicing is one of the most significant components generating functional diversity in many pathological conditions. The objective of this study was to analyse the mutations or aberrant splicing of A20 transcript, the region encompassing the ovarian tumour (OTU) domain [which is functionally important as an inhibitor of nuclear factor (NF)-κB activation] in fibroblast-like synoviocytes (FLSs) from RA patients. Methods. Alterations in A20 transcripts were determined through sequence analysis of 10 clones of A20 cDNA in FLSs from each of the five RA patients. The levels of aberrant A20 transcript were measured by quantitative real-time RT–PCR with primers to specifically recognize the inserted introns. The functional role of A20 and its aberrant variants were examined by analysing NF-κB luciferase reporter activity and NF-κB-dependent target gene expression. Results. In RA FLSs, we discovered four novel aberrant A20 transcripts, most of which resulted from insertion of partial intron 2, intron 4 and/or deletion of exon 4. In each of these FLSs, sequence analysis revealed that these aberrant insertional sequences were flanked by consensus splice donor and acceptor sequences without nucleotide substitution, suggesting alternative splicing as the likely mutational mechanism. These variants elicited a codon frame shift by creating a premature translational stop codon, and eventually, disruption of the OTU domain (which is functionally important as an inhibitor of NF-κB activation) of A20. The expression level of aberrant A20 transcript was correlated well with persisitently enhanced status of NF-κB signalling, as evident by the phosphorylation of inhibitor of NF-κB (IκB)-α and transcription of NF-κB target genes. Conclusion. The results suggest that A20 inactivation by the novel aberrant splicing may contribute to RA progression by inducing persistent NF-κB activation.Keywords
This publication has 35 references indexed in Scilit:
- Anti-TNF Treatment in Rheumatoid ArthritisCurrent Pharmaceutical Design, 2011
- Quantitation of glucocorticoid receptor alpha and NF-κB pathway mRNA and its correlation with disease activity in rheumatoid arthritis patientsGenetics and Molecular Research, 2010
- Gene discovery in rheumatoid arthritis highlights the CD40/NF‐ĸB signaling pathway in disease pathogenesisImmunological Reviews, 2009
- Molecular aspects of rheumatoid arthritis: chemokines in the joints of patientsThe FEBS Journal, 2008
- Signalling, inflammation and arthritis: NF- B and its relevance to arthritis and inflammationRheumatology, 2008
- Increased synovial tissue NF‐κB1 expression at sites adjacent to the cartilage–pannus junction in rheumatoid arthritisArthritis & Rheumatism, 2004
- Evolving concepts of rheumatoid arthritisNature, 2003
- NF-κB signaling pathways in mammalian and insect innate immunityGenes & Development, 2001
- Macrophage‐derived cytokine and nuclear factor κB p65 expression in synovial membrane and skin of patients with psoriatic arthritisArthritis & Rheumatism, 2000
- Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.Genes & Development, 1995